Валюты / KYMR
KYMR: Kymera Therapeutics Inc
44.90
USD
0.27
(0.60%)
Курс KYMR за сегодня изменился на 0.60%. При этом минимальная цена на торгах достигала 44.41, а максимальная — 45.83.
Следите за динамикой Kymera Therapeutics Inc. Котировки в реальном времени помогут быстро реагировать на изменения рынка. Переключаясь между различными таймфреймами, можно отслеживать тенденции и динамику курса по минутам, часам, дням, неделям и месяцам. Используйте эту информацию для прогнозирования изменений на рынке и принятия взвешенных торговых решений.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
Новости KYMR
- Benzinga Synovus Financial, Gilead Sciences And More On CNBC's 'Final Trades' - iShares U.S. Financial ETF (ARCA:IYF), Gilead Sciences (NASDAQ:GILD)
- Investing Kymera Therapeutics stock price target lowered to $65 at Brookline Capital
- Investing Morgan Stanley initiates Kymera Therapeutics stock with Overweight rating
- Investing Kymera Therapeutics Q4 2024 slides: immunology pipeline advances with $600M cash infusion
- Investing Tuesday’s Insider Activity: Major Buys and Sells Shake Up Markets
- Investing Kymera Therapeutics (KYMR) director group buys $13.9 million in stock
- Investing Monday’s Insider Activity: Top Buys and Sells in US Stocks
- Investing Kymera Therapeutics: Baker Bros acquire $28.8m in shares
- Investing Kymera price target raised to $54 from $51 at BofA on pipeline updates
- Investing Kymera’s partnerships with Sanofi and Gilead drive value
- Investing Kymera Therapeutics Announces Pricing of $250 Million Public Offering
- Benzinga Tesla To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday - Apple (NASDAQ:AAPL), Alnylam Pharmaceuticals (NASDAQ:ALNY)
- Investing Kymera stock price target raised to $60 from $54 at H.C. Wainwright
- Investing Kymera Therapeutics price target lowered to $70 at Brookline Capital
- Investing Kymera Therapeutics launches $250 million public stock offering
- Investing Kymera Therapeutics stock falls after announcing $250 million offering
- Investing Kymera stock falls as Jefferies lowers price target on program shifts
- Seeking Alpha Kymera Shrugs Off Sanofi Bust With Gilead Deal - But There Are Caveats (NASDAQ:KYMR)
- Investing Kymera stock falls as Sanofi drops IRAK4 degrader for next-gen candidate
- Benzinga Gilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies - Gilead Sciences (NASDAQ:GILD), Sanofi (NASDAQ:SNY)
- Investing Sanofi to advance Kymera’s oral IRAK4 degrader KT-485 to clinical testing
- Seeking Alpha Tracking Baker Brothers Portfolio – Q1 2025 Update
- Investing Kymera at Goldman Sachs Conference: Pioneering Oral Protein Degraders
- Benzinga Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? - Applied Digital (NASDAQ:APLD), Riot Platforms (NASDAQ:RIOT)
Дневной диапазон
44.41
45.83
Годовой диапазон
19.44
53.27
- Предыдущее закрытие
- 44.48
- Open
- 44.63
- Bid
- 44.90
- Ask
- 45.20
- Low
- 44.41
- High
- 45.83
- Объем
- 1.440 K
- Дневное изменение
- 0.60%
- Месячное изменение
- -0.27%
- 6-месячное изменение
- 17.54%
- Годовое изменение
- -3.61%
15 июля, вторник
11:00
ALL
- Акт.
- Прог.
- Пред.
12:30
USD
- Акт.
- Прог.
- -0.3%
- Пред.
- 0.1%
12:30
USD
- Акт.
- Прог.
- 0.2%
- Пред.
- 0.1%
12:30
USD
- Акт.
- Прог.
- 2.4%
- Пред.
- 2.4%
12:30
USD
- Акт.
- Прог.
- 2.7%
- Пред.
- 2.8%
12:30
USD
- Акт.
- Прог.
- 321.516
- Пред.
- 321.465
12:30
USD
- Акт.
- Прог.
- 327.606
- Пред.
- 326.854
12:30
USD
- Акт.
- Прог.
- 0.1%
- Пред.
- 0.3%
12:30
USD
- Акт.
- Прог.
- Пред.
- 0.2%
12:30
USD
- Акт.
- Прог.
- Пред.
- 0.2%
12:30
USD
- Акт.
- Прог.
- 320.395
- Пред.
- 320.580
12:30
USD
- Акт.
- Прог.
- Пред.
- 327.509
12:30
USD
- Акт.
- Прог.
- 2.2
- Пред.
- -16.0
13:15
USD
- Акт.
- Прог.
- Пред.
15:00
USD
- Акт.
- Прог.
- 0.2%
- Пред.
- 0.2%
16:45
USD
- Акт.
- Прог.
- Пред.